영상의학과 김영곤 교수

학력
1995.02	전북대학교 의학과 학사

경력
2017.04 ~현재	성균관대학교 의과대학 삼성서울병원 영상의학과 교수
2011.03 ~현재	성균관대학교 의과대학 삼성서울병원 영상의학과 부교수
2010.08 ~ 2011.02	삼성서울병원 임상부교수
2005.01 ~ 2010.07	전북대학교 의과대학 조교수
2002.01 ~ 2004.12	전북대학교병원 전임의, 임상교수
2001.01 ~ 2001.12	제주한국병원 진료과장
1997.01 ~ 2000.12	전북대학교병원 수련의

HPB 2025 10.1016/j.hpb.2024.10.015 Clinical significance of CA 19-9 elevation during postoperative surveillance for extrahepatic bile duct cancer: a nomogram-based approach for the prediction of short-term recurrence Kwon, YJ; Min, JH; Hwang, JA; Kim, SH; Kim, YK; Kim, H; Gu, K; Lee, JH; Shin, J; Choi, SY; Baek, SY

View PubMed

J CACHEXIA SARCOPENI 2024 10.1002/jcsm.13643 Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic Cancer Min, JH; Yu, JI; Kim, SH; Kim, YK; Kim, K; Park, HC; Park, JO; Hong, JY; Lee, KT; Lee, KH; Lee, JK; Park, JK; Choi, JH; Heo, JS; Han, IW; Kim, H; Shin, SH; Yoon, SJ; Woo, SY

View PubMed

EUR J RADIOL 2024 10.1016/j.ejrad.2024.111505 Should we suspect gallbladder cancer if which CT finding is observed in patients with localized gallbladder wall thickening? Min, JH; Choi, SY; Kim, SH; Kim, YK; Hwang, JA; Cha, DI; Lee, JH; Baek, SY; Lee, JE

View PubMed

EUR RADIOL 2024 10.1007/s00330-024-10780-x Prognostic significance of MRI features in patients with solitary large hepatocellular carcinoma following surgical resection Gu, KYW; Min, JH; Lee, JH; Shin, J; Jeong, WK; Kim, YK; Kim, H; Baek, SY; Kim, JM; Choi, GS; Rhu, J; Ha, SY

View PubMed

RADIOLOGY 2024 10.1148/radiol.233114 Comparison of Four Diagnostic Guidelines for Hepatocellular Carcinoma Using Gadoxetic Acid-enhanced Liver MRI Yoon, JH; Kim, YK; Kim, JW; Chang, W; Choi, JI; Park, BJ; Choi, JY; Kim, SS; Park, HS; Lee, ES; Yu, JS; Park, SJ; You, MW; Lee, CH; Lee, JM

View PubMed

MAGN RESON IMAGING 2024 10.1016/j.mri.2024.03.014 Magnetic resonance elastography as a preoperative assessment for predicting intrahepatic recurrence in patients with hepatocellular carcinoma Lee, JH; Hwang, JA; Gu, K; Shin, J; Han, S; Kim, YK

View PubMed

EUR J RADIOL 2023 10.1016/j.ejrad.2023.111183 The role of subspecialized radiologist reviews in preoperative conference for hepato-pancreato-biliary disease Seo, Y; Min, JH; Kim, SH; Kim, YK; Kim, H; Cha, DI; Lee, JH; Heo, JS; Han, IW; Shin, SH; Kim, H; Yoon, SJ; Choi, SY

View PubMed

CLIN IMAG 2023 10.1016/j.clinimag.2023.05.018 Comparison of noncontrast, dynamic, and hepatobiliary phase abbreviated MRI protocols for detection of hepatic malignancies Lee, JH; Kim, YK; Min, JH; Cha, D; Hwang, JA; Ahn, S

View PubMed

CANCER MED-US 2023 10.1002/cam4.5530 Comprehensive immunoprofile analysis of prognostic markers in pancreaticobiliary tract cancers Kim, JE; Kim, H; Kim, B; Chung, HG; Chung, HH; Kim, KM; Kim, SH; Jeong, WK; Kim, YK; Min, JH; Heo, JS; Han, IW; Shin, SH; Park, HC; Yu, JI; Park, JO; Kim, ST; Hong, JY; Lee, SH; Lee, KH; Lee, JK; Lee, KT; Jang, KT; Park, JK

View PubMed

AM J ROENTGENOL 2022 10.2214/AJR.22.27739 Utility of Diffusion-Weighted MRI for Detection of Locally Recurrent Pancreatic Cancer After Surgical Resection Shin, N; Kang, TW; Min, JH; Hwang, JA; Kim, YK; Kim, YY; Han, IW; Kim, K

View PubMed

EUR J RADIOL 2022 10.1016/j.ejrad.2022.110328 Association between intensity of imaging surveillance and clinical outcomes in patients with hepatocellular carcinoma Hwang, JA; Kang, TW; Min, JH; Kim, YK; Kim, SH; Sinn, DH; Kim, K

View PubMed

EUR RADIOL 2021 10.1007/s00330-021-07897-8 2021 Assessment of factors affecting washout appearance of hepatocellular carcinoma on CT Hwang¹, JA; Min, JH; Kang, TW; Jeong, WK; Kim, YK; Ko, SE; Choi, SY

View PubMed

EUR J RADIOL 2021 10.1016/j.ejrad.2020.109474 2021 Gadoxetic acid-enhanced MRI for differentiating hepatic sclerosing hemangioma from malignant tumor Kim¹, YY; Kang, TW; Cha, DI; Min, JH; Kim, YK; Kim, SH; Sinn, DH; Won, H; Kim, S

View PubMed

EUR RADIOL 2021 10.1007/s00330-020-07583-1 2021 Intraductal papillary mucinous neoplasm of the pancreas: diagnostic performance of the 2017 international consensus guidelines using CT and MRI Min¹, JH; Kim, YK; Kim, SK; Kim, H; Ahn, S

View PubMed

RADIOLOGY 2021 10.1148/radiol.2020200885 2021 Comparison of Super-Resolution US and Contrast Material-enhanced US in Detection of the Spoke Wheel Sign in Patients with Focal Nodular Hyperplasia Kang¹, TW; Jeong, WK; Kim, YY; Min, JH; Kim, YK; Kim, SH; Sinn, DH; Kim, K

View PubMed

MED ULTRASON 2021 10.11152/mu-2906 Quantitative analysis of contrast-enhanced ultrasonography following living donor liver transplantation: early diagnosis of middle hepatic venous occlusion Im, J; Jeong, WK; Lee, MW; Kim, YK; Min, JH; Kim, JM; Choi, GS; Joh, JW

View PubMed

KOREAN J RADIOL 2021 10.3348/kjr.2020.1428 Prognosis after Curative Resection of Single Hepatocellular Carcinoma with A Focus on LI-RADS Targetoid Appearance on Preoperative Gadoxetic Acid-Enhanced MRI Moon, JY; Min, JH; Kim, YK; Cha, D; Hwang, JA; Ko, SE; Choi, SY; Yun, EJ; Kim, SW; Won, HJ

View PubMed

EUR RADIOL 2021 10.1007/s00330-021-08124-0 A modified LI-RADS: targetoid tumors with enhancing capsule can be diagnosed as HCC instead of LR-M lesions Min, JH; Kim, JM; Kim, YK; Kim, H; Choi, GS; Kang, TW; Cha, D; Hwang, JA; Ko, SE; Ahn, S

View PubMed

LIVER INT 2021 10.1111/liv.15012 EASL versus LI-RADS: Intra-individual comparison of MRI with extracellular contrast and gadoxetic acid for diagnosis of small HCC Min, JH; Kim, JM; Kim, YK; Kim, H; Cha, DI; Kang, TW; Choi, GS; Choi, SY; Ahn, S

View PubMed

EUR RADIOL 2020 10.1007/s00330-020-07438-9 2020 Vanishing washout of hepatocellular carcinoma according to the presence of hepatic steatosis diagnostic performance of CT and MRI Min¹, JH; Kang, TW; Kim, YY; Cha, DI; Kim, YK; Kim, SH; Sinn, DH; Ha, SY; Kim, K

View PubMed

CLIN GASTROENTEROL H 2020 10.1016/j.cgh.2019.12.010 2020 Magnetic Resonance Imaging With Extracellular Contrast Detects Hepatocellular Carcinoma With Greater Accuracy Than With Gadoxetic Acid or Computed Tomography Min¹, JH; Kim, JM; Kim, YK; Cha, DI; Kang, TW; Kim, H; Choi, GS; Choi, SY; Ahn, S

View PubMed

CLIN RADIOL 2020 10.1016/j.crad.2020.01.002 2020 Targetoid hepatic observations on gadoxetic acid-enhanced MRI using LI-RADS version 2018: emphasis on hepatocellular carcinomas assigned to the LR-M category Park¹, HJ; Kim, YK; Cha, DI; Ko, SE; Kim, S; Lee, ES; Ahn, S

View PubMed

RADIOLOGY 2020 10.1148/radiol.2020190639 2020 Use of Gadoxetic Acid enhanced Liver MRI and Morality in More than 30000 Patients with Hepatocellular Carcinoma: A Nationwide Analysis Kang¹, TW; Kong, SY; Kang, D; Kang, MW; Kim, YK; Kim, SH; Sinn, DH; Kim, YA; Choi, KS; Lee, ES; Cho, J; Guallar, E; Back, JH; Woo, SM

View PubMed

KOREAN J RADIOL 2020 10.3348/kjr.2019.0538 2020 Preoperative Prediction for Early Recurrence Can Be as Accurate as Postoperative Assessment in Single Hepatocellular Carcinoma Patients Cha¹, DI; Jang, KM; Kim, SH; Kim, YK; Kim, H; Ahn, SH

View PubMed

CLIN RADIOL 2020 10.1016/j.crad.2019.11.004 2020 Comparison of the diagnostic performance of the 2017 and 2018 versions of LI-RADS for hepatocellular carcinoma on gadoxetic acid enhanced MRI Ko¹, A; Park, HJ; Lee, ES; Park, SB; Kim, YK; Choi, SY; Ahn, S

View PubMed

EUR RADIOL 2020 10.1007/s00330-020-06753-5 2020 Extracellular contrast-enhanced MRI with diffusion-weighted imaging for HCC diagnosis: prospective comparison with gadoxetic acid using LI-RADS Cha¹, DI; Choi, GS; Kim, YK; Kim, JM; Kang, TW; Song, KD; Ahn, SH

View PubMed

Abdom Radiol (NY) 2019 10.1007/s00261-019-02068-2 2019 Differentiation of hypervascular primary hepatic tumors showing hepatobiliary hypointensity on gadoxetic acid-enhanced magnetic resonance imaging Park¹, HJ; Kim, YK; Min, JH; Lee, J; Lee, SJ; Lee, ES; Ahn, S

View PubMed

Abdom Radiol (NY) 2019 10.1007/s00261-019-01968-7 2019 Diagnosis of recurrent HCC: intraindividual comparison of gadoxetic acid MRI and extracellular contrast-enhanced MRI Yim¹, JH; Kim, YK; Min, JH; Lee, J; Kang, TW; Lee, SJ

View PubMed

ACTA RADIOL 2019 10.1177/0284185118805253 2019 Evaluation of early treatment response to radiotherapy for HCC using pre- and post-treatment MRI Song¹, SH; Jeong, WK; Choi, D; Kim, YK; Park, HC; Yu, JI

View PubMed

CLIN IMAG 2019 10.1016/j.clinimag.2019.02.013 2019 Usefulness of non-contrast MR imaging in distinguishing pancreatic ductal adenocarcinoma from focal pancreatitis Lee¹, JH; Min, JH; Kim, YK; Cha, DI; Lee, J; Park, HJ; Ahn, S

View PubMed

MEDICINE 2019 10.1097/MD.0000000000015867 2019 Semiautomatic software for measurement of abdominal muscle and adipose areas using computed tomography A STROBE-compliant article Kim¹, SS; Kim, JH; Jeong, WK; Lee, J; Kim, YK; Choi, D; Lee, WJ

View PubMed

Abdom Radiol (NY) 2019 10.1007/s00261-018-1847-y 2019 Differentiation between inflammatory myofibroblastic tumor and cholangiocarcinoma manifesting as target appearance on gadoxetic acid-enhanced MRI Chang¹, AI; Kim, YK; Min, JH; Lee, J; Kim, H; Lee, SJ

View PubMed

EUR RADIOL 2019 10.1007/s00330-018-5771-x 2019 Intra-individual comparison of gadolinium-enhanced MRI using pseudo-golden-angle radial acquisition with gadoxetic acid-enhanced MRI for diagnosis of HCCs using LI-RADS Kim¹, YC; Min, JH; Kim, YK; Lee, SJ; Ahn, S; Kim, E; Peeters, H

View PubMed

ACTA RADIOL 2019 10.1177/0284185118788901 2019 Non-contrast liver MRI as an alternative to gadoxetic acid-enhanced MRI for liver metastasis from colorectal cancer Hwang¹, JA; Kim, YK; Min, JH; Song, KD; Sohn, I; Ahn, HS

View PubMed

RADIOLOGY 2019 10.1118/radiol.2018181485 2019 Intrahepatic Mass-formimg Cholangiocarcinoma: Arterial Enhancement Patterns at MRI and Prognosis Min¹, JH; Kim, YK; Choi, SY; Kang, TW; Lee, SJ; Kim, JM; Ahn, S; Cho, H

View PubMed

CLIN IMAG 2019 10.1016/j.clinimag.2018.12.001 2019 Usefulness of noncontrast MRI in differentiation between gallbladder carcinoma and benign conditions manifesting as focal mild wall thickening Cha¹, SY; Kim, YK; Min, JH; Lee, J; Cha, DI; Lee, SJ

View PubMed

KOREAN J RADIOL 2019 10.3348/kjr.2018.0339 2019 Identification of Arterial Hyperenhancement in CT and MRI in Patients with Hepatocellular Carcinoma: Value of Unenhanced Images Kim¹, M; Kang, TW; Cha, DI; Jang, KM; Kim, YK; Kim, SH; Sinn, DH; Kim, K

View PubMed

HEPATOLOGY 2018 10.1002/hep.30122 2018 Prospective Intraindividual Comparison of Magnetic Resonance Imaging With Gadoxetic Acid and Extracellular Contrast for Diagnosis of Hepatocellular Carcinomas Using the Liver Imaging Reporting and Data System Min¹, JH; Kim, JM; Kim, YK; Kang, TW; Lee, SJ; Choi, GS; Choi, SY; Ahn, S

View PubMed

Abdom Radiol (NY) 2018 10.1007/s00261-018-1653-6 2018 Hepatic neuroendocrine tumors: gadoxetic acid-enhanced magnetic resonance imaging findings with an emphasis on differentiation between primary and secondary tumors Cha¹, DI; Kang, TW; Jang, KM; Kim, YK; Kim, SH; Ha, SY; Sohn, I

View PubMed

BRIT J RADIOL 2018 10.1259/bjr.20180177 2018 Detection of recurrent hepatocellular carcinoma after surgical resection: Non-contrast liver MR imaging with diffusion-weighted imaging versus gadoxetic acid-enhanced MR imaging Min¹, JH; Kim, YK; Choi, SY; Kang, TW; Jeong, WK; Kim, K; Won, HJ

View PubMed

Abdom Radiol (NY) 2018 10.1007/s00261-018-1480-9 2018 Adding ancillary features to enhancement patterns of hepatocellular carcinoma on gadoxetic acid-enhanced magnetic resonance imaging improves diagnostic performance Min¹, JH; Kim, YK; Sinn, DH; Choi, SY; Jeong, WK; Lee, WJ; Ha, SY; Ahn, S; Kim, MJ

View PubMed

EUR RADIOL 2018 10.1007/s00330-018-5307-4 2018 Artifacts during the arterial phase of gadoxetate disodium-enhanced MRI: Multiple arterial phases using view-sharing from two different vendors versus single arterial phase imaging Min¹, JH; Kim, YK; Kang, TW; Jeong, WK; Lee, WJ; Ahn, S; Hwang, NY

View PubMed

ACTA RADIOL 2018 10.1177/0284185117728534 2018 Intra-individual comparison of hepatocellular carcinoma imaging computed tomconstrast-enhancedtte computed tomography, gadopentetate dimeglumine-enhanced MRI, and gadoxetic acid-enhanced MRI Kim¹, YN; Song, JS; Moon, WS; Hwang, HP; Kim, YK

View PubMed

J HEPATOL 2018 10.1016/j.jhep.2018.01.024 2018 Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma Kim¹, AY; Sinn, DH; Jeong, WK; Kim, YK; Kang, TW; Ha, SY; Park, CK; Choi, GS; Kim, JM; Kwon, CHD; Joh, JW; Kim, MJ; Sohn, I; Jung, SH; Paik, SW; Lee, WJ

View PubMed

CLIN RADIOL 2018 10.1016/j.crad.2018.01.016 2018 Prediction and clinical implications of portal vein/superior mesenteric vein invasion in patients with resected pancreatic head cancer: the significance of preoperative CT parameters Kim¹, M; Kang, TW; Cha, DI; Kim, YK; Kim, SH; Jang, KT; Han, IW; Sohn, I

View PubMed

EUR RADIOL 2018 10.1007/s00330-017-5196-y 2018 Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging Choi¹, SY; Kim, YK; Min, JH; Kang, TW; Jeong, WK; Ahn, S; Won, H

View PubMed

EUR RADIOL 2018 10.1007/s00330-017-5248-3 2018 Hepatic neuroendocrine tumour: Apparent diffusion coefficient as a potential marker of prognosis associated with tumour grade and overall survival Min¹, JH; Kang, TW; Kim, YK; Kim, SH; Shin, KS; Lee, JE; Ha, SY; Sohn, I

View PubMed

ACTA RADIOL 2018 10.1177/0284185117723040 2018 Hepatocellular carcinoma with central scar on gadoxetic acid-enhanced and diffusion-weighted magnetic resonance imaging Han¹, SB; Kim, YK; Min, JH; Ha, SY; Jeong, WK; Lee, WJ

View PubMed

EUR RADIOL 2018 10.1007/s00330-017-4926-5 2018 Comparison between MRI with MR cholangiopancreatography and endoscopic ultrasonography for differentiating malignant from benign mucinous neoplasms of the pancreas Hwang¹, J; Kim, YK; Min, JH; Jeong, WK; Hong, SS; Kim, HJ

View PubMed

CLIN IMAG 2018 10.1016/j.clinimag.2017.08.004 2018 The qualitative and quantitative image analysis of MR imaging in patients with acute-on-chronic liver failure Kang¹, TW; Kim, M; Kim, YK; Kim, SH; Sinn, DH; Kim, K

View PubMed

CLIN RADIOL 2017 10.1016/j.crad.2017.07.009 2017 Value of unenhanced MRI with diffusion-weighted imaging for detection of primary small (<= 20 mm) solid pancreatic tumours and prediction of pancreatic ductal adenocarcinoma Park¹, HJ; Jang, KM; Song, KD; Kim, SH; Kim, YK; Cha, MJ; Choi, SY; Min, K

View PubMed

EUR RADIOL 2017 10.1007/s00330-017-4846-4 2017 Capsule, septum, and T2 hyperintense foci for differentiation between large hepatocellular carcinoma (>= 5 cm) and intrahepatic cholangiocarcinoma on gadoxetic acid MRI Hwang¹, J; Kim, YK; Min, JH; Choi, SY; Jeong, WK; Hong, SS; Kim, HJ; Ahn, S; Ahn, HS

View PubMed

ACTA RADIOL 2017 10.1177/0284185116685921 2017 Diagnostic accuracy of diffusion restriction in intraductal papillary mucinous neoplasm of the pancreas in comparison with "high-risk stigmata'' of the 2012 international consensus guidelines for prediction of the malignancy and invasiveness Kim¹, M; Jang, KM; Kim, SH; Song, KD; Jeong, WK; Kang, TW; Kim, YK; Cha, DI; Kim, K; Yoo, H

View PubMed

EUR J RADIOL 2017 10.1016/j.ejard.2017.036 2017 Association between non-hypervascular hypointense nodules on gadoxetic acid-enhanced MRI and liver stiffness or hepatocellular carcinoma Hwang¹, JA; Kang, TW; Kim, YK; Kim, SH; Paik, YH; Ha, SY; Kim, S

View PubMed

EUR RADIOL 2017 10.1007/s00330-017-4782-3 2017 The value of gadoxetic acid-enhanced MRI for differentiation between hepatic microabscesses and metastases in patients with periampullary cancer Choi¹, SY; Kim, YK; Min, JH; Cha, DI; Jeong, WK; Lee, WJ

View PubMed

Abdom Radiol (NY) 2017 10.1007/s00261-017-1119-2 2017 Magnetic resonance findings of hepatic epithelioid hemangioendothelioma: emphasis on hepatobiliary phase using Gd-EOB-DTPA Lee¹, JH; Jeong, WK; Kim, YK; Lee, WJ; Ha, SY; Kim, KW; Kim, J

View PubMed

Clin Neuroradiol 2017 10.1007/s00062-016-0508-1 2017 Differentiation of Hemangioblastoma from Metastatic Brain Tumor using Dynamic Contrast-enhanced MR Imaging Cha¹, J; Kim, ST; Nam, DH; Kong, DS; Kim, HJ; Kim, YK; Kim, HY; Park, GM; Jeon, P; Kim, KH; Byun, HS

View PubMed

EUR RADIOL 2017 10.1007/s00330-016-4662-2 2017 Gadoxetic acid-enhanced magnetic resonance imaging characteristics of hepatocellular carcinoma occurring in liver transplants Kim¹, M; Kang, TW; Jeong, WK; Kim, YK; Kim, SH; Kim, JM; Sinn, DH; Kim, MJ; Jung, SH

View PubMed

EUR RADIOL 2017 10.1007/s00330-016-4644-4 2017 Disappearing or residual tiny (ae<currency>5 mm) colorectal liver metastases after chemotherapy on gadoxetic acid-enhanced liver MRI and diffusion-weighted imaging: Is local treatment required? Kim¹, SS; Song, KD; Kim, YK; Kim, HC; Huh, JW; Park, YS; Park, JO; Kim, ST

View PubMed

EUR J RADIOL 2017 10.1016/j.ejrad.2017.04.008 2017 Differentiation between cholangiocarcinoma and hepatocellular carcinoma with target sign on diffusion-weighted imaging and hepatobiliary phase gadoxetic acid-enhanced MR imaging: Classification tree analysis applying capsule and septum Min¹, JH; Kim, YK; Choi, SY; Jeong, WK; Lee, WJ; Ha, SY; Ahn, S; Ahn, HS

View PubMed

Korean J Radiol. 2017 May-Jun;18(3):427-443. doi: 10.3348/kjr.2017.18.3.427. Epub 2017 Apr 3. 2017 Diagnosis of Hepatocellular Carcinoma with Gadoxetic Acid-Enhanced MRI: 2016 Consensus Recommendations of the Korean Society of Abdominal. Radiology ¹,Korean Society of Abdominal Radiology.

View PubMed

Abdom Radiol (NY). 2017 May;42(5):1424-1433. doi: 10.1007/s00261-016-1038-7. 2017 Imaging features of hepatic sarcomatous carcinoma on computed tomography and gadoxetic acid-enhanced magnetic resonance imaging Gu KW1¹, Kim YK2, Min JH1, Ha SY3, Jeong WK1.

View PubMed

Eur Radiol. 2017 Apr;27(4):1722-1732. doi: 10.1007/s00330-016-4522-0. Epub 2016 Aug 10. 2017 Differentiation of mass-forming focal pancreatitis from pancreatic ductal adenocarcinoma: value of characterizing dynamic enhancement patterns on contrast-enhanced MR images by adding signal intensity color mapping Kim M1¹, Jang KM2,3, Kim JH4, Jeong WK4, Kim SH4, Kang TW4, Kim YK4, Cha DI4, Kim K5.

View PubMed

Acta Radiol. 2016 Dec;57(12):1429-1437. doi: 10.1177/0284185115626472. Epub 2016 Jul 19. 2016 Iterative reconstruction: comparison of techniques for reduced-dose liver computed tomography following transarterial chemoembolization for hepatocellular carcinoma Cha MJ1¹, Jeong WK1, Choi D1, Kim YK1, Lim S1,2, Choi SY1,3, Lee WJ1.

View PubMed

Eur Radiol. 2016 Sep;26(9):3102-11. doi: 10.1007/s00330-015-4136-y. Epub 2015 Dec 3. 2016 Identification of Imaging Predictors Discriminating Different Primary Liver Tumours in Patients with Chronic Liver Disease on Gadoxetic Acid-enhanced MRI: a Classification Tree Analysis Park HJ1¹, Jang KM2, Kang TW3, Song KD3, Kim SH3, Kim YK3, Cha DI3, Kim J4, Goo J4.

View PubMed

Clin Radiol. 2016 Apr;71(4):402.e9-402.e15. doi: 10.1016/j.crad.2016.01.004. Epub 2016 Feb 10. 2016 Tumefactive gallbladder sludge: the MRI findings Seong M1¹, Kang TW2, Kim M1, Kim SS1, Jang KM1, Kim YK1, Kim SH1.

View PubMed

Eur J Radiol. 2016 Mar;85(3):680-7. doi: 10.1016/j.ejrad.2015.12.029. Epub 2016 Jan 4. 2016 Pancreatic neuroendocrine tumour: Correlation of apparent diffusion coefficient or WHO classification with recurrence-free survival Kim M1¹, Kang TW2, Kim YK1, Kim SH1, Kwon W3, Ha SY4, Ji SA5.

View PubMed

Medicine (Baltimore). 2016 Feb;95(7):e2718. doi: 10.1097/MD.0000000000002718. 2016 Predicting Hepatic Steatosis in Living Liver Donors via Noninvasive Methods Kim JM1¹, Ha SY, Joh JW, Sinn DH, Jeong WK, Choi GS, Gwak GY, Kwon CH, Kim YK, Paik YH, Lee JH, Lee WJ, Lee SK, Park CK.

View PubMed

Korean J Radiol. 2015 Sep-Oct;16(5):1038-46. doi: 10.3348/kjr.2015.16.5.1038. Epub 2015 Aug 21. 2015 T2-Weighted Liver MRI Using the MultiVane Technique at 3T: Comparison with Conventional T2-Weighted MRI Kang KA1¹, Kim YK2, Kim E3, Jeong WK2, Choi D2, Lee WJ2, Jung SH4, Baek SY4.

View PubMed

Eur J Radiol. 2015 Aug;84(8):1473-9. doi: 10.1016/j.ejrad.2015.05.012. Epub 2015 May 18. 2015 Missed pancreatic ductal adenocarcinoma: Assessment of early imaging findings on prediagnostic magnetic resonance imaging Jang KM1¹, Kim SH2, Kim YK1, Song KD1, Lee SJ1, Choi D1.

View PubMed

Radiology.?2015 Oct;277(1):309. doi: 10.1148/radiol.2015154031. 2015 Nonhypervascular Hypointense Nodules at Gadoxetic Acid-enhanced MR Imaging in Chronic Liver Disease: Diffusion-weighted Imaging for Characterization Hwang J¹,?Kim YK,?Jeong WK,?Choi D,?Rhim H,?Lee WJ.

View PubMed

Eur Radiol. 2015 Jun;25(6):1551-60. doi: 10.1007/s00330-014-3548-4. Epub 2014 Dec 14. 2015 Pancreatic duct "Icicle sign" on MRI for distinguishing autoimmune pancreatitis from pancreatic ductal adenocarcinoma in the proximal pancreas Kim HJ1¹, Kim YK, Jeong WK, Lee WJ, Choi D.

View PubMed

Eur J Radiol. 2015 Jun;84(6):1036-43. doi: 10.1016/j.ejrad.2015.03.002. Epub 2015 Mar 14. 2015 Prediction of microvascular invasion of hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging: Impact of intra-tumoral fat detected on chemical-shift images Min JH1¹, Kim YK2, Lim S3, Jeong WK1, Choi D1, Lee WJ1.

View PubMed

Acta Radiol. 2015 May;56(5):526-35. doi: 10.1177/0284185114534652. Epub 2014 May 16. 2015 Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease Jang KM1¹, Kim SH2, Kim YK1, Choi D1.

View PubMed

Korean J Radiol. 2015 May-Jun;16(3):465-522. doi: 10.3348/kjr.2015.16.3.465. Epub 2015 May 13. 2015 2014 Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guideline for the Management of Hepatocellular Carcinoma Korean Liver Cancer Study Group (KLCSG); National Cancer Center¹, Korea (NCC).

View PubMed

Clin Radiol. 2015 Apr;70(4):408-15. doi: 10.1016/j.crad.2014.12.007. Epub 2015 Jan 2. 2015 Diffusion-weighted imaging of the liver at 3 T using section-selection gradient reversal: emphasis on chemical shift artefacts and lesion conspicuity Lee JS1¹, Kim YK2, Jeong WK1, Choi D1, Lee WJ1.

View PubMed

Abdom Imaging.?2015 Apr;40(4):835-42. doi: 10.1007/s00261-014-0249-z. 2015 Frequency, CT findings, and fate of multiple infarcted regenerative nodules in liver cirrhosis after variceal bleeding or septic shock Lee S1¹,?Choi D,?Jeong WK,?Kim YK,?Lim JH,?Choi MS,?Park CK.

View PubMed

Clin Radiol. 2015 Feb;70(2):153-60. doi: 10.1016/j.crad.2014.10.010. Epub 2014 Nov 22. 2015 Differentiation of solid-type serous cystic neoplasm from neuroendocrine tumour in the pancreas: value of abdominal MRI with diffusion-weighted imaging in comparison with MDCT Jang KM1¹, Kim SH2, Song KD1, Kim YK1, Lee SJ1, Choi D1.

View PubMed

Magn Reson Imaging. 2014 Dec;32(10):1214-22. doi: 10.1016/j.mri.2014.08.029. Epub 2014 Sep 3. 2014 Is gadoxetic acid-enhanced MRI limited in tumor characterization for patients with chronic liver disease Kwon S1¹, Kim YK2, Park HJ3, Jeong WK1, Lee WJ1, Choi D1.

View PubMed

Liver Transpl. 2014 Dec;20(12):1436-46. doi: 10.1002/lt.23974. Epub 2014 Nov 7. 2014 Pretransplant Diagnosis of Hepatocellular Carcinoma by Gadoxetic Acid-Enhanced and Diffusion-Weighted Magnetic Resonance Imaging Hwang J1¹, Kim YK, Kim JM, Lee WJ, Choi D, Hong SS.

View PubMed

Radiology. 2014 Nov;273(2):433-43. doi: 10.1148/radiol.14132563. Epub 2014 Jul 4. 2014 Preoperative Detection of Small Pancreatic Adenocarcinoma: Value of Adding Diffusion-weighted Imaging to Conventional MR Imaging for Improving Confidence Level Park MJ1¹, Kim YK, Choi SY, Rhim H, Lee WJ, Choi D.

View PubMed

Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):814-21. doi: 10.1016/j.ijrobp.2014.03.020. 2014 The Role of Diffusion-Weighted Magnetic Resonance Imaging in the Treatment Response Evaluation of Hepatocellular Carcinoma Patients Treated With Radiation Therapy Yu JI1¹, Park HC2, Lim DH1, Choi Y1, Jung SH1, Paik SW3, Kim SH4, Jeong WK4, Kim YK4.

View PubMed

Magn Reson Imaging. 2014 Jul;32(6):610-8. doi: 10.1016/j.mri.2013.12.021. Epub 2014 Jan 13. 2014 Noncontrast MRI with diffusion-weighted imaging as the sole imaging modality for detecting liver malignancy in patients with high risk for hepatocellular carcinoma Kim YK1¹, Kim YK2, Park HJ1, Park MJ1, Lee WJ1, Choi D1.

View PubMed

J Magn Reson Imaging. 2014 May;39(5):1238-45. doi: 10.1002/jmri.24265. Epub 2013 Oct 17. 2014 Infiltrative hepatocellular carcinoma on gadoxetic acid-enhanced and diffusion-weighted MRI at 3.0T Lim S1¹, Kim YK, Park HJ, Lee WJ, Choi D, Park MJ.

View PubMed

Clin Radiol. 2014 Apr;69(4):416-23. doi: 10.1016/j.crad.2013.11.015. Epub 2014 Jan 20. 2014 Pancreatic ductal adenocarcinoma: Prevalence and diagnostic value of dark choledochal ring sign on T2-weighted MRI Cha DI1¹, Kim YK2, Choi SY1, Lim SH1, Choi D1, Lee WJ1.

View PubMed

J Magn Reson Imaging. 2014 Apr;39(4):842-52. doi: 10.1002/jmri.24237. Epub 2013 Sep 30. 2014 Assessing Patients With hepatocellular Carcinoma Meeting the Milan Criteria: Is Liver 3 Tesla MR With Gadoxetic Acid Necessary in Addition to Liver CT Cha DI1¹, Lee MW, Kim YK, Kim SH, Park HJ, Rhim H, Lim HK.

View PubMed

Radiology. 2014 Mar;270(3):768-76. doi: 10.1148/radiol.13130009. Epub 2013 Oct 30. 2014 Hilar Cholangiocarcinoma: Value of Adding DW Imaging to Gadoxetic Acid-enhanced MR Imaging with MR Cholangiopancreatography for Preoperative Evaluation Park MJ1¹, Kim YK, Lim S, Rhim H, Lee WJ.

View PubMed

Abdom Imaging. 2014 Feb;39(1):142-52. doi: 10.1007/s00261-013-0044-2. 2014 Feasibility of blood oxygenation level-dependent MRI at 3T in the characterization of hepatic tumors Park HJ1¹, Kim YK, Min JH, Lee WJ, Choi D, Rhim H.

View PubMed

Br J Radiol. 2014 Jan;87(1033):20130608. doi: 10.1259/bjr.20130608. Epub 2013 Nov 28. 2014 Gadoxetic acid-enhanced MRI for T-staging of gallbladder carcinoma: emphasis on liver invasion Hwang J1¹, Kim YK, Choi D, Rhim H, Lee WJ, Hong SS, Kim HJ, Chang YW.

View PubMed

J Magn Reson Imaging. 2014 Jan;39(1):31-41. doi: 10.1002/jmri.24122. Epub 2013 Sep 24 2014 Diagnosis of Focal Liver Lesions With Gadoxetic Acid-Enhanced MRI: Is a Shortened Delay Time Possible by Adding Diffusion-weighted Imaging Kim MY1¹, Kim YK, Park HJ, Park MJ, Lee WJ, Choi D.

View PubMed

J Comput Assist Tomogr. 2013 Nov-Dec;37(6):872-81. doi: 10.1097/RCT.0b013e31829d44c1. 2013 Scirrhous Hepatocellular Carcinoma on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging and Diffusion-Weighted Imaging: Emphasis on the Differentiation of Intrahepatic Cholangiocarcinoma Park MJ1¹, Kim YK, Park HJ, Hwang J, Lee WJ.

View PubMed

J Comput Assist Tomogr. 2013 Nov-Dec;37(6):856-61. doi: 10.1097/RCT.0b013e31829002ca. 2013 Unenhanced Magnetic Resonance Portography Using Repetitive Arterial or Vein Labeling Method at 3.0-T Hwang J1¹, Kim YK, Lee WJ, Choi D, Park MJ, Park HJ, Hong SS, Lee MH.

View PubMed

Abdom Imaging.?2013 Oct;38(5):1115-9. doi: 10.1007/s00261-013-9993-8. 2013 Intraductal growing acinar cell carcinoma of the pancreas Kim HJ1¹,?Kim YK,?Jang KT,?Lim JH.

View PubMed

Abdom Imaging. 2013 Oct;38(5):1082-90. doi: 10.1007/s00261-013-9989-4. 2013 Intraductal papillary neoplasm of the bile ducts: description of MRI and added value of diffusion-weighted MRI Yoon HJ1¹, Kim YK, Jang KT, Lee KT, Lee JK, Choi DW, Lim JH.

View PubMed

J Magn Reson Imaging. 2013 Aug;38(2):401-10. doi: 10.1002/jmri.23983. Epub 2013 Jan 4. 2013 Gadoxetic acid-enhanced fat suppressed three-dimensional T1-weighted MRI using a multiecho dixon technique at 3 tesla: Emphasis on image quality and hepatocellular carcinoma detection Lee MH1¹, Kim YK, Park MJ, Hwang J, Kim SH, Lee WJ, Choi D.

View PubMed

Abdom Imaging. 2013 Aug;38(4):793-801. doi: 10.1007/s00261-012-9943-x. 2013 Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma Park HJ1¹, Kim YK, Park MJ, Lee WJ.

View PubMed

Radiology. 2013 Apr;267(1):317-8. doi: 10.1148/radiol.13122186. 2013 Hypovascular Hypointense Nodules on Hepatocyte Phase Gadoxetic Acid-enhanced MR Images: Too Early or Too Progressed to Determine Hypervascularity Response ¹,Motosugi U.

View PubMed

Acta Radiol. 2013 Mar 1;54(2):127-36. doi: 10.1258/ar.2012.120262. Epub 2012 Nov 12. 2013 Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis Park MJ1¹, Kim YK, Lee MH, Lee JH.

View PubMed

2012 Differentiating Combined Hepatocellular and Cholangioc cinoma from Mass-Forming Intrahepatic Chol gioc cinoma Using Gadoxetic Acid-Enh ced MRI

View PubMed

Radiology. 2012 Oct;265(1):104-14. Epub 2012 Aug 13. 2012 Hypovascular Hypointense Nodules on Hepatobiliary Phase Gadoxetic Acid-enhanced MR Images in Patients with Cirrhosis: Potential of DW Imaging in Predicting Progression to Hypervascular HCC Kim YK1¹, Lee WJ, Park MJ, Kim SH, Rhim H, Choi D.

View PubMed

Acta Radiol. 2012 Oct 1;53(8):830-8. doi: 10.1258/ar.2012.120099. Epub 2012 Jul 30. 2012 Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis Kim AY1¹, Kim YK, Lee MW, Park MJ, Hwang J, Lee MH, Lee JW.

View PubMed

J Comput Assist Tomogr. 2012 Sep-Oct;36(5):546-53. 2012 Liver MRI at 3.0 Tesla: Comparison of Image Quality and Lesion Detectability Between Single-Source Conventional and Dual-Source Parallel Radiofrequency Transmissions Hwang J1¹, Kim YK, Park MJ, Lee MH, Kim SH, Lee WJ, Choi D.

View PubMed

Radiology. 2012 Sep;264(3):761-70. doi: 10.1148/radiol.12112517. Epub 2012 Jul 27. 2012 Small Hepatocellular Carcinomas: Improved Sensitivity by Combining Gadoxetic Acid-enhanced and Diffusion-weighted MR Imaging Patterns Park MJ1¹, Kim YK, Lee MW, Lee WJ, Kim YS, Kim SH, Choi D, Rhim H.

View PubMed

Clin Radiol. 2012 Aug;67(8):766-73. doi: 10.1016/j.crad.2012.01.004. Epub 2012 Mar 15. 2012 Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using gadoxetic acid-enhanced MRI Chong YS1¹, Kim YK, Lee MW, Kim SH, Lee WJ, Rhim HC, Lee SJ.

View PubMed

Acta Radiol. 2012 Jun 1;53(5):485-93. doi: 10.1258/ar.2012.110437. Epub 2012 Apr 25. 2012 Detection and characterization of small focal hepatic lesions (<= 2.5 cm in diameter): a comparison of diffusion-weighted images before and after administration of gadoxetic acid disodium at 3.0T Song KD1¹, Kim YK, Lee WJ, Lee MW, Park MJ, Hwang J, Lee MH.

View PubMed

Br J Radiol. 2012 May;85(1013):539-47. doi: 10.1259/bjr/25139667. 2012 Diagnostic efficacy of gadoxetic acid-enhanced MRI for the detection and characterisation of liver metastases: comparison with multidetector-row CT Kim YK1¹, Park G, Kim CS, Yu HC, Han YM.

View PubMed

Invest Radiol. 2012 Mar;47(3):159-66. doi: 10.1097/RLI.0b013e31823a1495. 2012 Diagnostic Accuracy and Sensitivity of Diffusion-Weighted and of Gadoxetic Acid-Enhanced 3-T MR Imaging Alone or in Combination in the Detection of Small Liver Metastasis (<= 1.5 cm in Diameter) Kim YK1¹, Lee MW, Lee WJ, Kim SH, Rhim H, Lim JH, Choi D, Kim YS, Jang KM, Lee SJ, Lim HK.

View PubMed

AJR Am J Roentgenol. 2011 Nov;197(5):1111-20. doi: 10.2214/AJR.10.6363. 2011 Cyst-Forming Intraductal Papillary Neoplasm of the Bile Ducts: Description of Imaging and Pathologic Aspects Lim JH1¹, Zen Y, Jang KT, Kim YK, Nakanuma Y.

View PubMed

Clin Radiol. 2011 Jun;66(6):489-96. doi: 10.1016/j.crad.2010.09.007. Epub 2011 Mar 1. 2011 Detection of liver malignancy with gadoxetic acid-enhanced MRI: Is addition of diffusion-weighted MRI beneficial (vol 66, pg 489, 2011) Kim YK1¹, Kim CS, Han YM, Lee YH.

View PubMed

Invest Radiol. 2011 Jun;46(6):383-9. doi: 10.1097/RLI.0b013e318217b8fb. 2011 Detection of Small Hepatocellular Carcinoma: Intraindividual Comparison of Gadoxetic Acid-Enhanced MRI at 3.0 and 1.5 T (vol 46, pg 383, 2011) Kim YK1¹, Kim CS, Han YM, Yu HC, Choi D.

View PubMed

Abdom Imaging. 2011 Aug;36(4):425-32. doi: 10.1007/s00261-011-9752-7. 2011 Differentiating focal eosinophilic liver disease from hepatic metastases using unenhanced and gadoxetic acid-enhanced MRI Kim YK1¹, Lee YH, Kim CS, Lee MW.

View PubMed

Invest Radiol. 2011 Jun;46(6):383-9. doi: 10.1097/RLI.0b013e318217b8fb. 2011 Detection of Small Hepatocellular Carcinoma Intraindividual Comparison of Gadoxetic Acid-Enhanced MRI at 3.0 and 1.5 T Kim YK1¹, Kim CS, Han YM, Yu HC, Choi D.

View PubMed

Br J Radiol. 2010 Dec;83(996):1010-6. doi: 10.1259/bjr/66686028. Epub 2010 Aug 3. 2010 Diagnostic efficacy of gadoxetic acid-enhanced MRI in the detection of hepatocellular carcinomas: comparison with gadopentetate dimeglumine Park G1¹, Kim YK, Kim CS, Yu HC, Hwang SB.

View PubMed

J Atheroscler Thromb. 2010 Dec 26;17(12):1218-25. Epub 2010 Aug 27. 2010 Serum Folate and Low-Density Lipoprotein Particle Size Kim DS1¹, Kim YK, Park HK, Cho YI, Jeong SK.

View PubMed

Invest Radiol. 2010 Nov;45(11):740-6. doi: 10.1097/RLI.0b013e3181e943a7. 2010 Detection of Small Hepatocellular Carcinoma Can Gadoxetic Acid-Enhanced Magnetic Resonance Imaging Replace Combining Gadopentetate Dimeglumine-Enhanced and Superparamagnetic Iron Oxide-Enhanced Magnetic Resonance Imaging Kim YK1¹, Kim CS, Han YM, Park G.

View PubMed

날짜					목 01	금 02	토 03	일 04	월 05	화 06	수 07	목 08	금 09	토 10	일 11	월 12	화 13	수 14	목 15	금 16	토 17	일 18	월 19	화 20	수 21	목 22	금 23	토 24	일 25	월 26	화 27	수 28	목 29	금 30	토 31
오전
오후

날짜	일 01	월 02	화 03	수 04	목 05	금 06	토 07	일 08	월 09	화 10	수 11	목 12	금 13	토 14	일 15	월 16	화 17	수 18	목 19	금 20	토 21	일 22	월 23	화 24	수 25	목 26	금 27	토 28	일 29	월 30
오전
오후

게재일	2014-10-22
발표년월	2012-05	구분	국내
학술지	가정의학회지
논문명(국문)
논문명(영문)
요약문	td	발행정보	2010;31(10):778-785
책임저자	이정권
저자	박주현, 이선진, 곽정임, 심재용, 이정권	제 1저자	박주현
초록첨부	test
논문첨부

영상의학과 김영곤 교수

학력

경력